Mylan Inc. (NYSE: MYL) announced that its subsidiary Alphapharm Pty Limited won a favorable decision in patent litigation against it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE